Skip to main content
hello world

BriaCell Therapeutics: Bottom 25 Performing Stocks Year-to-Date on TSX (BCT)

AI-generated - The Globe and Mail - Wed Jun 19, 11:30PM CDT

BriaCell Therapeutics Corp is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.

This report is generated monthly. It highlights the 25 companies with the greatest percentage decrease in share price year-to-date. Stocks in this category are generally sold to preserve capital or held for speculation.

Companies experiencing dramatic increases in share price can do so for a variety of reasons – including bearish changes in sector outlook, or the company is experiencing financial difficulties generally due to an inability to service its debt.

SymbolNameTotal ReturnPeriod
HZMHorizonte Minerals PLC-97.368421YTD
LPENLoop Energy Inc-80YTD
CJR-BCorus Entertainment Inc-78.873239YTD
NCUNevada Copper Corp-76.923077YTD
BCTBriaCell Therapeutics Corp-76.410256YTD
TAIGTaiga Motors Corp-66.292135YTD
APSAptose Biosciences Inc-64.776119YTD
EXROExro Technologies Inc-62.109375YTD
GFPGreenFirst Forest Products Inc-59.473684YTD
EGLXEnthusiast Gaming Holdings Inc-56.140351YTD
CHWChesswood Group Ltd-55.99022YTD
SSRMSSR Mining Inc-55.766526YTD
NUMINuminus Wellness Inc-54.545455YTD
LACLithium Americas Corp-54.470588YTD
AVNTAvant Brands Inc-53.571429YTD
SOT-UNSlate Office REIT-52.469136YTD
SVASernova Corp-51.428571YTD
AMMAlmaden Minerals Ltd-51.351351YTD
INO-UNInovalis Real Estate Investment Trust-50.588235YTD
ASNDAscendant Resources Inc-50YTD
WRXWestern Resources Corp-46.666667YTD
TWMTidewater Midstream and Infrastructure Ltd-46.226415YTD
NPKVerde AgriTech Ltd-45.22293YTD
HOT-UAmerican Hotel Income Properties REIT LP-44.53125YTD
SMCSulliden Mining Capital Inc-42.857143YTD

All data provided as of June 18, 2024.

More about BriaCell Therapeutics Corp

BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.

BriaCell Therapeutics Corp is listed under BCT on the Toronto Stock Exchange.

Artificial intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.